Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 1,112 | 1,711 | 1,691 | 11,935 | 3,674 |
| Gross Profit | 1,112 | 1,711 | 1,691 | 11,935 | 3,674 |
| Operating Expenses | 9,440 | 9,419 | 7,120 | 5,549 | 9,063 |
| Operating Income | -8,328 | -7,708 | -5,429 | 6,386 | -5,389 |
| Other Income | 563 | 602 | 632 | -811 | 428 |
| Pre-tax Income | -7,765 | -7,106 | -4,797 | 5,575 | -4,961 |
| Income Tax | N/A | N/A | -2 | 14 | N/A |
| Net Income Continuous | -7,765 | -7,106 | -4,795 | 5,561 | -4,961 |
| Net Income | $-7,765 | $-7,106 | $-4,795 | $5,561 | $-4,961 |
| EPS Basic Total Ops | -0.30 | -0.29 | -0.20 | 0.26 | -0.24 |
| EPS Basic Continuous Ops | -0.30 | -0.29 | -0.21 | 0.26 | -0.24 |
| EPS Diluted Total Ops | -0.30 | -0.29 | -0.19 | 0.25 | -0.24 |
| EPS Diluted Continuous Ops | -0.30 | -0.29 | -0.20 | 0.25 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.30 | -0.29 | -0.21 | N/A | N/A |
| EBITDA(a) | $-8,328 | $-7,708 | $-5,426 | $6,387 | $-5,388 |